In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users Read More > June 6, 2011
Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives Read More > April 8, 2011
The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations Read More > March 1, 2011
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs Read More > February 15, 2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens Read More > January 20, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Read More > January 3, 2011
Exploring the impact of ketamine on the experience of illusory body ownership Read More > January 1, 2011
Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others Read More > December 15, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Read More > December 3, 2010
